Eight-week test of VSJ-110 versus placebo for dry eye

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This phase 2 interventional trial compares VSJ-110 to a placebo over an eight-week treatment period in adults with dry eye. Participants receive either VSJ-110 or a matching placebo and attend scheduled visits for symptom assessments and safety monitoring. Primary data collected will include changes in dry eye signs and symptoms and adverse event reporting. The trial is being run at multiple Vanda investigational sites in the United States.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Be at least 18 years of age of either gender and any race.
* Provide written informed consent and sign the HIPAA form.
* Be willing and able to follow all instructions and attend all study visits.

Exclusion Criteria:

* Use of any of the disallowed medications during the washout and study period.

Where it's running

• Vanda Investigational Site
  Newport Beach, California, United States Recruiting
• Vanda Investigational Site
  Memphis, Tennessee, United States Recruiting
• Vanda Investigational Site
  Andover, Massachusetts, United States Not yet recruiting
• Vanda Investigational Site
  Shelby, North Carolina, United States Not yet recruiting
• Vanda Investigational Site
  Lynchburg, Virginia, United States Not yet recruiting

Study contacts

• Study coordinator: Vanda Pharmaceuticals
• Email: clinicaltrials@vandapharma.com
• Phone: 202-734-3400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lacrifill to Help Prevent Post-Curgery Dry Eye After Cataract Surgery

  This study tests Lacrifill to see if it helps prevent dry eye symptoms after unilateral cataract surgery.

  Recruiting at 2 sites Phase 4 Eye Research Associates, LLC · Pittsburg, Kansas and 1 other locations · NCT07796178

• Tear-Fluid Stability Testing with iTrace, BOSA, OPD-Scan III, and IDRA for Dry Eye

  A Phase 4 study tests whether four eye devices can detect tear film stability in adults with normal tear film.

  Recruiting Phase 4 Vance Thompson Vision · Sioux Falls, South Dakota · NCT07790211

• OT202 1% eye drops for moderate to severe dry eye

  This phase 3 study tests whether 1% OT202 eye drops help people with moderate to severe dry eye better than a placebo.

  Recruiting Phase 3 Ocumension Therapeutics (Suzhou) Co., Ltd · Bengbu, Anhui and 48 other locations · NCT07740564

• Tyrvaya Nasal Spray for Comfort in Contact Lens Wearers

  This study tests whether using Tyrvaya twice daily can improve comfort for adults who wear soft contact lenses and have dry eye symptoms.

  Recruiting Ocular Aesthetics, LLC dba Ocular Clinical Trials · Houston, Texas · NCT07705893

• Long-term effects of Acoltremon vs. control in dry eye disease

  This study tests whether Acoltremon eye drops help people with dry eye over a year compared with a preservative-free artificial tear, at a single center.

  Recruiting The Eye Care Institute · Louisville, Kentucky · NCT07659626

• Effect of Dry Eye Treatment on Corneal Astigmatism Measurements

  This study tests whether short-term treatment for dry eye changes how consistently three devices measure corneal astigmatism in people preparing for cataract surgery.

  Recruiting Eye & ENT Hospital of Fudan University · Shanghai, Shanghai Municipality · NCT07657858

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.